Drugs / CEFAMANDOLE
CEFAMANDOLE
also known as
Cefamandol · CEFAMANDOLE SODIUM · Cephamandole · COMPOUND 83405 · J01DC03 · NSC-758169
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CEFAMANDOLE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1146 ↗ |
| Known as | Cefamandol | “Cefamandol” NCT02099240 ↗ |
| Known as | CEFAMANDOLE SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL1146 ↗ |
| Known as | Cephamandole | ChEMBL registry synonym — accepted as the source's own label CHEMBL1146 ↗ |
| Known as | COMPOUND 83405 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1146 ↗ |
| Known as | J01DC03 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1146 ↗ |
| Known as | NSC-758169 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1146 ↗ |
| Modality | Small molecule | — CHEMBL1146 ↗ |